Novarad has entered into a strategic alliance with a network of well-established specialty neurosurgical and spine distribution partners within the U.S. The initial network covers locations from the Eastern seaboard to Texas, with additional partners to be added throughout the entire country in 4Q22. These medical device distributors bring widespread experience and a strong local presence to support the growth of Novarad’s new VisAR and OpenSight product lines.
VisAR, a revolutionary Augmented Reality Surgical Navigation technology, received FDA 510(k) clearance earlier this year. Presenting as a 3-dimensional hologram visible through an optical visor, this augmented reality is superimposed onto the patient with sub-millimeter accuracy and obviates the need for a separate monitor.
With a broad reach, Novarad’s patented innovation transforms both surgeries and medical education by providing real-time viewing of anatomy and critical structures on the patient.
Dr. Wendell Gibby, Novarad’s founder and CEO, said, “Like a surgical GPS, VisAR provides a roadmap to guide the surgeon to the pathology of interest.” Easy to expand with a reduced IT footprint, VisAR’s size and scalability can benefit physicians and hospitals alike.
Novarad has entered into a strategic alliance with a network of well-established specialty neurosurgical and spine distribution partners within the U.S. The initial network covers locations from the Eastern seaboard to Texas, with additional partners to be added throughout the entire country in 4Q22. These medical device distributors bring...
Novarad has entered into a strategic alliance with a network of well-established specialty neurosurgical and spine distribution partners within the U.S. The initial network covers locations from the Eastern seaboard to Texas, with additional partners to be added throughout the entire country in 4Q22. These medical device distributors bring widespread experience and a strong local presence to support the growth of Novarad’s new VisAR and OpenSight product lines.
VisAR, a revolutionary Augmented Reality Surgical Navigation technology, received FDA 510(k) clearance earlier this year. Presenting as a 3-dimensional hologram visible through an optical visor, this augmented reality is superimposed onto the patient with sub-millimeter accuracy and obviates the need for a separate monitor.
With a broad reach, Novarad’s patented innovation transforms both surgeries and medical education by providing real-time viewing of anatomy and critical structures on the patient.
Dr. Wendell Gibby, Novarad’s founder and CEO, said, “Like a surgical GPS, VisAR provides a roadmap to guide the surgeon to the pathology of interest.” Easy to expand with a reduced IT footprint, VisAR’s size and scalability can benefit physicians and hospitals alike.
Copy to clipboard 
